Thomas Andresen

Thomas Andresen

Company: T-Cypher Bio

Job title: CEO


Finding Effective Methods to Discover TCRs to Ensure Maximum Treatment Ability 11:45 am

• Evaluating what an ‘excellent’ TCR looks like to recognize ideal characteristics • Reviewing TCR discovery methods to distinguish advantageous approaches • Assessing TCR safety to ensure few off-target effects in the context of HLA • Utilizing a high-throughput discovery platform to identify effective TCRsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.